Advertisement

Picture Kentro Design Is Key to Your Success Berlin 650x100px

Deals > All

Find below a list of collaborations and financings!

Total search results: 786 | Ordered by Date (descending)
1 2 3 4 5 6 7 8  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Agilent–Plasmion: ionisation technology, 202301– collab co-marketing of SICRIT ion source with Agilent Ultivo LC/TQ + LC/MSD iQ MS systems 2023-01-18
Siemens–ASG Superconductors: magnetic resonance imaging, 202301– collab integration of ASG MRI magnets >7T in Siemens Healthineers UFH MRI systems 2023-01-18
InDevR–Adjuvant Capital: investment, 202301 financing round Series B totalling $9m incl $4m from Adjuvant Capital 2023-01-17
InDevR–Mérieux: investment, 202301 financing round Series B totalling $9m incl $5m from bioMérieux in connection w partnership 2023-01-17
InDevR–SEVERAL: investment, 202301 financing round Series B $9m from bioMérieux + Adjuvant Capital 2023-01-17
Mérieux–InDevR: VaxArray platform, 202301– excl distribution of VaxArray portfolio by bioMérieux in Europe 2023-01-17
Delta Precision–Astrea Bioseparations: investment, 202301 acquisition of Delta Precision Ltd by Astrea 2023-01-09
Evosep–Novo Group: investment, 202301 minority investment of $40m by Novo Holdings A/S 2023-01-09
Acquifer Imaging–Bruker: investment, 202201 acquisition €na of Acquifer Imaging Gmbh + subsidiary Deltabyte GmbH by Bruker 2023-01-05
Biognosys–Bruker: investment, 202301 acquisition €na of majority share in Biognosys by Bruker 2023-01-04
Numares–EU (govt): credit, 202212– quasi-equity venture debt financing up to €20m from EIB 2022-12-20
Numares–SEVERAL: investment, 202212 financing round €20m from existing investors 2022-12-20
Cellesce–Danaher: investment, 202212 acquisition of Cellesce by Molecular Devices 2022-12-06
Neurescence–Bruker: investment, 202211–202212 acquisition 100% of Neurescence Inc by Bruker 2022-11-14
Elemental Machines–SEVERAL: investment, 202211 financing round Series B $41m led by Sageview Capital 2022-11-10
Inscopix–Bruker: investment, 202211 acquisition €na of Inscopix by Bruker 2022-11-08
Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED 2022-10-31
MS-Omics–Clinical Microbiomics: investment, 202210 acquisition of MS-Omics ApS by Clinical Microbiomics A/S 2022-10-17
Cevec–Danaher: investment, 202210 acquisition of Cevec by Cytiva 2022-10-06
Irubis–EU (govt): investment, 202210 seed financing round totalling €2.8m incl co-investor EIC Fund 2022-10-06
Irubis–High-Tech Gründerfonds: investment, 202210 seed financing round totalling €2.8m incl co-lead investor HTGF 2022-10-06
Irubis–OTHER: investment, 202210 seed financing round totalling €2.8m incl business angels as co-investors 2022-10-06
Irubis–SEVERAL: investment, 202210 seed financing round €2.8m led by HTGF + Verve Ventures + Ventura BioMed Investors 2022-10-06
Irubis–TU Munich: investment, 202210 seed financing round totalling €2.8m incl co-investor Initiative for Industrial Innovators 2022-10-06
Irubis–Ventura Biomed Investors: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Ventura Biomed Investors 2022-10-06
Irubis–Verve Capital Partners: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Verve Ventures 2022-10-06
Agilent–Scitara: lab informatics, 202209– collab product integration of OpenLab CDS + SLIMS with Scientific Integration Platform SIP + DLX 2022-09-21
ValitaCell–Danaher: investment, 202209 acquisition of ValitaCell by Beckman Coulter Life Sciences 2022-09-13
2bind–Dynamic Biosensors: switchSENSE technology, 202209– collab technology-service with 2bind using HeliX biosensor system as certified beta customer 2022-09-01
Trace Analytics–908 Devices: investment, 202208 acquisition $15.3m upfront cash + $2m cash milestones 2022-08-09
Atlas Antibodies–Genovis: MS-based analysis of biopharmaceuticals, 202208– supply service LC-MS analytics of recombinant CHO-antibodies to Evitria 2022-08-08
NeoSphere Biotechnologies–SEVERAL: investment, 202207 financing round Series A 2022-07-25
SPT Labtech–EQT: investment, 202206– acquisition £650m of SPT Labtech by EQT IX Fund from Battery Ventures 2022-06-22
ModuVision–Knauer: investment, 202206 acquisition of ModuVision by Knauer 2022-06-13
Peptone–Bessemer Venture: investment, 202206 financing round Series A totalling $40m incl co-lead investor Bessemer Venture Partners 2022-06-09
Peptone–F-Prime: investment, 202206 financing round Series A totalling $40m incl co-lead investor F-Prime Capital 2022-06-09
Peptone–Hoxton Ventures: investment, 202206 financing round Series A totalling $40m incl existing + co-investor Hoxton Ventures 2022-06-09
Peptone–Novartis: investment, 202206 financing round Series A totalling $40m incl existing + co-investor dRX Capital 2022-06-09
Peptone–Nvidia: AI-based drug discovery, 202206 collab incl use of Nvidia DGX A100 supercomputer to run Peptone’s algorithmic engine 2022-06-09
Peptone–SEVERAL: investment, 202206 financing round Series A $40m led by F-Prime + Bessemer Venture Partners 2022-06-09
Peptone–Walden Catalyst: investment, 202206 financing round Series A totalling $40m incl co-investor Walden Catalyst Vemtures 2022-06-09
Agilent–Mettler-Toledo: lab automation, –202206 collab developm + product integration automated + digitalised sample prep for LC/GC workflow 2022-06-01
Weezion–Mérieux: in-vitro diagnostics, 202206– collab technical assistance from bioMérieux to develop MS-based sepsis IVD 2022-06-01
Weezion–Mérieux: investment, 202206 investment €2m from bioMérieux for a 4.26% share accompanied by technical assistance 2022-06-01
Irubis–EU (govt): grant, 202005– grant €1.3m from EIC Accelerator Pilot Programme 2022-05-26
OMass–SEVERAL: investment, 202204 financing round Series B £75.5m led by new investors GV + Northpond Ventures + Sanofi Ventures 2022-04-28
Peak Proteins–Sygnature Discovery: investment, 202204 acquisition €na of Peak Proteins by Sygnature Discovery 2022-04-26
PerkinElmer–Scitara: lab informatics, 202204– collab product integration of Signals informatics platform with Scientific Integration Platform SIP 2022-04-14
IonSense–Bruker: investment, 202204 acquisition of IonSense by Bruker 2022-04-06
Optimal Industrial–Bruker: investment, 202204 acquisition €na of Optimal Industrial Automation + Technologies by Bruker 2022-04-05
Irubis–EU (govt): credit, 202203– convertible loan €500k from EIC Fund as part of EIC Accelerator Pilot programme 2022-03-24
Biogenity–Denmark (govt): investment, 202203 Innovation Fund Denmark invests in Innobooster project BioSWITCH 2022-03-23
PrognomiQ–Bruker: investment, 202203 financing round totalling $46m incl lead investor Bruker Corp 2022-03-15
PrognomiQ–SEVERAL: investment, 202203 financing round $46m led by Bruker Corp 2022-03-15
Fluidigm–Casdin Capital: investment, 202201–202204 acquisition totalling $250m zero-coupon convertible preferred shares incl Casdin Capital 2022-01-24
Fluidigm–SEVERAL: investment, 202201–202204 acquisition $250m zero-coupon convertible preferred shares by Casdin Capital + Viking Global Investors 2022-01-24
Fluidigm–Viking Global Investors: investment, 202201–202204 acquisition totalling $250m zero-coupon convertible preferred shares incl Viking 2022-01-24
Prolab Instruments–Bruker: investment, 202201 acquisition €na of Prolab Instruments Gmbh by Bruker 2022-01-19
PreOmics–Bruker: investment, 202201 acquisition €na of shares of HTGF + Think.Health Ventures + certain business angels by Bruker 2022-01-18
PreOmics–Bruker: investment, 202201 Series B investment €13.5m from Bruker tog w secondary transaction making Bruker majority shareholder 2022-01-18
ProtaGene–Ampersand: investment, 202201 existent portfolio company after merger/acquisition of PPS GmbH + BioAnalytix + GeneWerk GmbH in 7/21 2022-01-12
Rockefeller Univ–Lumicks: microscope, 202201 supply of Quadrupole C-Trap system to lab of Prof Michael O’Donnell 2022-01-12
Creoptix–Spectris: investment, 202201 acquisition of Creoptix AG by Malvern Panalytical 2022-01-11
Scitara–Flybridge Capital: investment, 202201 financing round Series B totalling $15m incl existing + co-investor Flybridge Capital 2022-01-11
Scitara–Northpond Ventures: investment, 202201 financing round Series B totalling $15m incl existing + lead investor Northpond Ventures 2022-01-11
Scitara–Scott Partnership: public relations, 202201 service existent by Scott PR 2022-01-11
Scitara–SEVERAL: investment, 202201 financing round Series B $15m led by Northpond Ventures 2022-01-11
GSK–908 Devices: mass spectrometer, 202201 supply GSK purchases 5th Rebel CE-MS-based cell culture media analyser from 908 Devices 2022-01-07
Exelead–Merck (DE): investment, 202201 acquisition $760m in cash by Merck 2022-01-06
Protai Bio–Grove Ventures: investment, 202201 seed financing round totalling $8m incl co-lead investor Grove Ventures 2022-01-05
Protai Bio–Pitango: investment, 202201 seed financing round totalling $8m incl co-lead investor Pitango HealthTech 2022-01-05
Protai Bio–SEVERAL: investment, 202201 seed financing round $8m co-led by Grove Ventures + Pitango HealthTech 2022-01-05
Protein Metrics–Insightful Science: investment, 202112 acquisition of Protein Metrics by Insightful Science 2021-12-21
Lonza–Agilent: analytical instruments, 202112– strategic alliance to integrate analytical technologies in Cocoon cell therapy production platform 2021-12-15
Merck (DE)–Merck (DE): investment, 202112 third increase of financial commitment by €600m in evergreen corporate venture fund M Ventures 2021-12-08
Molecubes–Bruker: investment, 202111 acquisition €na by Bruker 2021-11-19
Axel Semrau–Trajan: investment, 202111 acquisition €19.85m by Trajan Group 2021-11-18
908 Devices–SEVERAL: investment, 202111 public offering $100.8m net $94.4m with 3.15m shares common stock at $32/share 2021-11-15
Bruker–Bico: MS-based single cell proteomics, 202111– co-marketing of Cellenion’s cellenONE with timsTOF SCP mass spectrometers 2021-11-15
Thermo Fisher–Bico: MS-based single cell proteomics, 202111– co-marketing Cellenion’s cellenONE + proteoCHIP with Orbitrap MS systems + TMT technology 2021-11-15
LabArchives–Insightful Science: investment, 202111 acquisition of LabArchies by Insightful Science 2021-11-10
Danaher–Evosep: MS-based proteomics, 202111– collab developm proteomics workflows w joint customers using Evosep One + Sciex ZenoTOF 7600 system 2021-11-01
DNA Script–Agilent: investment, 202110 financing round Series C totalling $165m incl existing + co-investor Agilent Technologies 2021-10-26
DNA Script–Danaher: investment, 202110 financing round Series C totalling $165m incl existing + co-investor Danaher Life Sciences 2021-10-26
DNA Script–SEVERAL: investment, 202110 financing round Series C $165m co-led by Coatue Management + Catalio Capital Management 2021-10-26
TrueMass–Scott Partnership: public relations, 202110 service existent by Scott PR 2021-10-26
QInstruments–Bico: investment, 202110 acquisition 100% cash/debt free for €58.25m upfront + €3m milestones thereof 13% paid in new Bico shares 2021-10-01
Thermo Fisher–Carbon Engineering: analytical technology, 202109 collab existent direct air capture technology to reduce CO2 emissions 2021-09-23
Hurel–Bico: investment, 202109 acquisition $2.5m of assets + operations of Hurel Corp + integration in Visikol 2021-09-15
Agena Bioscience–Mesa Labs: investment, 202109– acquisition $300m in cash of Agena by Mesa Laboratories ANNOUNCED 2021-09-14
De Novo Software–Insightful Science: investment, 202109 acquisition of De Novo Software by Insightful Science 2021-09-14
Evotec–Biognosys: MS-based proteomics, 202109– collab integration of Spectronaut proteomics data analys into drug discovery + clinical proteomics 2021-09-14
Owlstone–Horizons Ventures: investment, 202109 financing round Series D totalling $58m incl existing + lead investor Horizons Ventures 2021-09-07
Owlstone–SEVERAL: investment, 202109 financing round Series D $58m of Owlstone Medical led by existing investor Horizons Ventures 2021-09-07
Biognosys–ETH Zürich: LiP technology, 202108 collab developm + excl license from Institute of Systems Biology 2021-08-27
Spectricity–SEVERAL: investment, 202108 financing round Series B €14m 2021-08-03
Nuvisan–ALS Ltd: investment, 202207 strategic investment acquiring 49% stake in Nuvisan to expand ALS Life Sciences network 2021-07-28
BioLegend–PerkinElmer: investment, 202107– acquisition $5.25b in cash + shares subject to certain adjustments ANNOUNCED 2021-07-26
Excellims–Covalent Bonds: public relations, 202107 service existent by Covalent Bonds 2021-07-21
Mobilion–Agilent: investment, 202107 financing round Series C totalling $60m incl existing + co-investor Agilent Technologies 2021-07-13
1 2 3 4 5 6 7 8  next pagenext page



Advertisement

Picture University of Siena imss2023 Cagliari Sardinia Italy 650x100px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com


Advertisement

Picture Wirtschaftsförderung Sachsen Life Sciences in Saxony 650x300px

» top